Ensol Biosciences Inc. (XKON:140610)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,170
+50 (0.35%)
At close: Mar 9, 2026

Ensol Biosciences Market Cap

Ensol Biosciences has a market cap or net worth of 191.69 billion as of March 9, 2026. Its market cap has decreased by -49.12% in one year.

Market Cap
191.69B
Enterprise Value
n/a
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
14,170.00

Market Cap Chart

Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 191.69B, an increase of 80.49%. That is a compound annual growth rate of 8.19%.

History

DateMarket Cap% Change
Mar 9, 2026191.69B9.17%
Dec 30, 2025175.59B-10.18%
Dec 30, 2024195.49B264.72%
Dec 28, 202353.60B-23.21%
Dec 29, 202269.80B-47.06%
Dec 30, 2021131.85B5.52%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Kangstem Biotech 189.05B
QuadMedicine 186.24B
TiumBio 197.44B
Prestige Biologics 202.16B
ISU Abxis 206.04B
Genome & Company 245.30B
ABION 259.94B
Bio Solution 281.61B
Market Cap Rankings